BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 25617172)

  • 41. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
    Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hypoparathyroidism treated with recombinant human parathyroid hormone [rhPTH(1-84)]].
    Ramacciotti CF; Pereyra MC; Cohen EN
    Medicina (B Aires); 2020; 80(3):289-291. PubMed ID: 32442945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.
    Cusano NE; Rubin MR; McMahon DJ; Zhang C; Ives R; Tulley A; Sliney J; Cremers SC; Bilezikian JP
    J Clin Endocrinol Metab; 2013 Jan; 98(1):137-44. PubMed ID: 23162103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report.
    Saraiva M; Chaves AC; Assunção G; Saraiva J; Carvalho R
    Am J Case Rep; 2021 Aug; 22():e931739. PubMed ID: 34389697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hypoparathyroidism: the present state of art].
    Krysiak R; Handzlik-Orlik G; Kedzia A; Machnik G; Okopień B
    Wiad Lek; 2013; 66(1):18-29. PubMed ID: 23905424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New directions in the treatment of hypoparathyroidism.
    Hamny I; Chanson P; Borson-Chazot F
    Ann Endocrinol (Paris); 2023 Aug; 84(4):460-465. PubMed ID: 37080533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoparathyroidism: is it that easy to treat?
    Triantafyllou E; Yavropoulou MP; Anastasilakis AD; Makras P
    Hormones (Athens); 2019 Mar; 18(1):55-63. PubMed ID: 29876797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypocalcemic disorders.
    Bove-Fenderson E; Mannstadt M
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):639-656. PubMed ID: 30449546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parathyroid hormone levels predict posttotal thyroidectomy hypoparathyroidism.
    Rivere AE; Brooks AJ; Hayek GA; Wang H; Corsetti RL; Fuhrman GM
    Am Surg; 2014 Aug; 80(8):817-20. PubMed ID: 25105405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism.
    Holten-Andersen L; Pihl S; Rasmussen CE; Zettler J; Maitro G; Baron J; Heinig S; Hoffmann E; Wegge T; Krusch M; Faltinger F; Killian S; Sprogoe K; Karpf DB; Breinholt VM; Cleemann F
    J Bone Miner Res; 2019 Nov; 34(11):2075-2086. PubMed ID: 31291476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PTH replacement therapy of hypoparathyroidism.
    Rejnmark L; Sikjaer T; Underbjerg L; Mosekilde L
    Osteoporos Int; 2013 May; 24(5):1529-36. PubMed ID: 23184178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update.
    Iglesias P; Díez JJ
    Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):497-505. PubMed ID: 28444664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the treatment of hypoparathyroidism with PTH 1-34.
    Winer KK
    Bone; 2019 Mar; 120():535-541. PubMed ID: 30243992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Update on recent progress in vitamin D research. Vitamin D treatment for hypoparathyroidism.].
    Minagawa M
    Clin Calcium; 2017; 27(11):1623-1628. PubMed ID: 29074836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conventional Treatment of Hypoparathyroidism.
    Babey M; Brandi ML; Shoback D
    Endocrinol Metab Clin North Am; 2018 Dec; 47(4):889-900. PubMed ID: 30390820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia.
    Sabour S; Manders E; Steward DL
    Otolaryngol Head Neck Surg; 2009 Dec; 141(6):727-9. PubMed ID: 19932845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.
    Tay YD; Tabacco G; Cusano NE; Williams J; Omeragic B; Majeed R; Gomez Almonte M; Bilezikian JP; Rubin MR
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5601-5610. PubMed ID: 31310310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postsurgical Hypoparathyroidism: A Systematic Review.
    Kakava K; Tournis S; Papadakis G; Karelas I; Stampouloglou P; Kassi E; Triantafillopoulos I; Villiotou V; Karatzas T
    In Vivo; 2016; 30(3):171-9. PubMed ID: 27107072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.
    Aouchiche K; Reynaud R; Amodru V; Brue T; Cuny T
    Endocrine; 2022 Apr; 76(1):179-188. PubMed ID: 34984624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
    Gonzales MC; Lieb DC; Richardson DW; O'Brian JT; Aloi JA; Khardori RK
    Endocr Pract; 2013; 19(1):e24-8. PubMed ID: 23186954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.